COVID-19 incidence, severity, medication use, and vaccination among dentists: survey during the second wave in Brazil.

Journal of applied oral science : revista FOB Pub Date : 2022-10-03 eCollection Date: 2022-01-01 DOI:10.1590/1678-7757-2022-0016
Rafael R Moraes, Marcos B Correa, Paulo R Martins-Filho, Giana S Lima, Flavio F Demarco
{"title":"COVID-19 incidence, severity, medication use, and vaccination among dentists: survey during the second wave in Brazil.","authors":"Rafael R Moraes,&nbsp;Marcos B Correa,&nbsp;Paulo R Martins-Filho,&nbsp;Giana S Lima,&nbsp;Flavio F Demarco","doi":"10.1590/1678-7757-2022-0016","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This cross-sectional study with dentists in Brazil assessed the COVID-19 incidence and severity, its vaccination status, and the level of confidence in vaccines in May 2021 (COVID-19 second wave). The medications used to prevent or treat COVID-19, including controversial substances (vitamin D, ivermectin, zinc, and chloroquine), were analyzed.</p><p><strong>Methodology: </strong>Dentists were recruited by email and responded to a pretested questionnaire until May 31, 2021. Bivariate and multivariate regression analyses were performed (α=0.05). Prevalence ratios were calculated for the association between professional characteristics and two outcomes: SARS-CoV-2 infection and use of controversial substances.</p><p><strong>Results: </strong>In total, 1,907 responses were received (return rate of 21.2%). One third of dentists reported intermediate levels of confidence in the safety and efficacy of COVID-19 vaccines, but 96% had received at least one vaccine dose, mainly CoronaVac. The effect of the pandemic on dental practice was classified as lower/much lower, in comparison with the first wave, by 46% of participants. Moreover, 27% of dentists had already tested positive for SARS-CoV-2 and about 50% had relatives or friends who had been hospitalized or died from COVID-19. At least one medication was used by 59% of participants and 43% used two or more substances. Vitamin D (41%), ivermectin (35%), and zinc (29%) were the most frequent substances. More experienced dentists (≥21 years of professional experience) were 42% more likely to use controversial substances than less experienced dentists. The prevalence of use of controversial substances was 30% higher among dentists with residency or advanced training, such as postgraduate degrees, in comparison with participants holding MSc or PhD degrees. Participants with low confidence in vaccines were 2.1 times more likely to use controversial substances than participants with a very high confidence.</p><p><strong>Conclusion: </strong>The results of this study show the high severity of the COVID-19 pandemic in Brazil and raised questions about the use of scientific evidence by dentists in their decision to use controversial substances.</p>","PeriodicalId":321675,"journal":{"name":"Journal of applied oral science : revista FOB","volume":" ","pages":"e20220016"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529204/pdf/","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of applied oral science : revista FOB","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/1678-7757-2022-0016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Objective: This cross-sectional study with dentists in Brazil assessed the COVID-19 incidence and severity, its vaccination status, and the level of confidence in vaccines in May 2021 (COVID-19 second wave). The medications used to prevent or treat COVID-19, including controversial substances (vitamin D, ivermectin, zinc, and chloroquine), were analyzed.

Methodology: Dentists were recruited by email and responded to a pretested questionnaire until May 31, 2021. Bivariate and multivariate regression analyses were performed (α=0.05). Prevalence ratios were calculated for the association between professional characteristics and two outcomes: SARS-CoV-2 infection and use of controversial substances.

Results: In total, 1,907 responses were received (return rate of 21.2%). One third of dentists reported intermediate levels of confidence in the safety and efficacy of COVID-19 vaccines, but 96% had received at least one vaccine dose, mainly CoronaVac. The effect of the pandemic on dental practice was classified as lower/much lower, in comparison with the first wave, by 46% of participants. Moreover, 27% of dentists had already tested positive for SARS-CoV-2 and about 50% had relatives or friends who had been hospitalized or died from COVID-19. At least one medication was used by 59% of participants and 43% used two or more substances. Vitamin D (41%), ivermectin (35%), and zinc (29%) were the most frequent substances. More experienced dentists (≥21 years of professional experience) were 42% more likely to use controversial substances than less experienced dentists. The prevalence of use of controversial substances was 30% higher among dentists with residency or advanced training, such as postgraduate degrees, in comparison with participants holding MSc or PhD degrees. Participants with low confidence in vaccines were 2.1 times more likely to use controversial substances than participants with a very high confidence.

Conclusion: The results of this study show the high severity of the COVID-19 pandemic in Brazil and raised questions about the use of scientific evidence by dentists in their decision to use controversial substances.

牙医中COVID-19的发病率、严重程度、药物使用和疫苗接种:巴西第二波调查
目的:对巴西牙医进行横断面研究,评估2021年5月(COVID-19第二波)的COVID-19发病率和严重程度、疫苗接种状况和疫苗置信度。分析了用于预防或治疗COVID-19的药物,包括有争议的物质(维生素D、伊维菌素、锌、氯喹)。方法:通过电子邮件招募牙医,并在2021年5月31日之前回答一份预测问卷。进行双因素和多因素回归分析(α=0.05)。计算职业特征与两种结果(SARS-CoV-2感染和使用有争议物质)之间的相关性的流行率。结果:共收到问卷1907份,回收率为21.2%。三分之一的牙医报告说,他们对COVID-19疫苗的安全性和有效性有中等程度的信心,但96%的牙医至少接种了一剂疫苗,主要是冠状病毒疫苗。46%的参与者认为,与第一波疫情相比,疫情对牙科执业的影响较低/低得多。此外,27%的牙医已经检测出SARS-CoV-2呈阳性,约50%的牙医有亲戚或朋友因COVID-19住院或死亡。59%的参与者至少使用一种药物,43%的参与者使用两种或两种以上的药物。维生素D(41%)、伊维菌素(35%)和锌(29%)是最常见的物质。经验丰富的牙医(≥21年的专业经验)使用有争议物质的可能性比经验不足的牙医高42%。与拥有硕士或博士学位的参与者相比,拥有住院医师或高级培训(如研究生学位)的牙医使用有争议物质的比例高出30%。对疫苗缺乏信心的参与者使用有争议物质的可能性是信心非常高的参与者的2.1倍。结论:本研究的结果显示了巴西COVID-19大流行的高度严重性,并对牙医在决定使用有争议物质时使用科学证据提出了质疑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信